Sanjivani Paranteral Balance Sheet Annual

BSE: 531569 | NSE: - | ISIN: INE860D01013 | Sector: Biotechnology & Drugs

289.85 0.00 (0.00%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash	9.02	-	-	-
Cash Equivalents	0.54	0.30	0.34	0.17
Cashand Short Term Investments	9.56	0.30	0.34	0.17
Accounts Receivable- Trade Net	4.70	1.99	4.92	6.63
Total Receivables Net	8.45	2.27	5.15	6.92
Total Inventory	9.73	5.35	1.75	0.91
Other Current Assets Total	0.89	0.34	0.49	1.17
Total Current Assets	28.64	8.27	7.73	9.18
Property/ Plant/ Equipment Total- Net	9.94	7.57	7.42	7.62
Long Term Investments	0.00	0.05	0.05	0.05
Note Receivable- Long Term	3.90	3.88	2.00	1.38
Other Long Term Assets Total	0.92	1.24	1.10	1.04
Total Assets	43.41	21.01	18.30	19.28
Accounts Payable	5.74	13.72	11.44	10.59
Notes Payable/ Short Term Debt	0.00	1.73	0.00	36.60
Other Currentliabilities Total	8.04	7.20	10.45	6.11
Total Current Liabilities	13.78	22.65	21.89	57.63
Long Term Debt	0.97	0.76	2.75	5.30
Total Long Term Debt	0.97	0.76	2.75	5.30
Total Debt	0.97	2.49	2.75	46.24
Deferred Income Tax	0.40	0.31	0.92	0.88
Other Liabilities Total	0.35	0.36	0.32	0.36
Total Liabilities	15.51	24.08	25.88	64.17
Common Stock Total	11.68	10.00	10.00	8.50
Other Equity Total	16.21	-13.07	-17.58	-53.39
Total Equity	27.90	-3.07	-7.58	-44.89
Total Liabilities Shareholders' Equity	43.41	21.01	18.30	19.28
Total Common Shares Outstanding	1.17	1.00	1.00	0.85
Tangible Book Valueper Share Common Eq	23.88	-3.07	-7.58	-52.83
Current Portof LT Debt/ Capital Leases	-	-	-	4.33